The DOI matches its Crossref record.
The human immune response to reconstituted bovine collagen.
Abstract
The human immune response to bovine dermal collagen was characterized through histologic, serologic, and immunoblotting methods. Collagen-sensitive patients were identified by hypersensitivity to intradermal exposure to ZYDERM Collagen Implant--a pepsin-solubilized, reconstituted, bovine dermal collagen. Biopsies of test sites in the forearm were obtained from several collagen-sensitive patients. Histologic examination revealed an implant-associated palisading foreign body granuloma. The lesion also contained a mixed cell infiltrate of histiocytes, lymphocytes, and eosinophils. Sera were collected from patients who developed erythema or induration at intradermal test or treatment sites, and were evaluated for antibodies to bovine dermal collagen by an enzyme-linked immunosorbent assay (ELISA). Sera with anti-collagen antibodies were further characterized in this study. The circulating antibodies were reactive with both native and heat-denatured bovine dermal collagen. By using purified alpha 1(I) and alpha 2(I) polypeptides, these sera were found to have antibodies reactive with both alpha-chains. Each alpha-chain was fragmented by using cyanogen bromide (CB). The CB peptides were electrophoretically separated, and these sera were evaluated for antibodies to the major fragments by using an immunoblotting technique. Of the sera evaluated by this method, 89% (23/26) had antibodies to alpha 1-CB6; 77% (20/26) had antibodies to alpha 2-CB4; and 65% (17/26) had antibodies reactive with both CB fragments. In addition, most sera (77%) contained antibodies reactive with two or more (up to five) of the major CB peptides. The least antigenic fragment was alpha 2-CB3,5 (8%). In addition, these sera had antibody activity against both native and heat-denaturated bovine types III and II collagens. Little or no interspecies (rat or guinea pig) cross-reactivity (types I and II) was detected. Furthermore, these sera did not have antibodies against human types I, II, and III collagens.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
GOVENDER, S., CSIMMA, C., GENANT, H. K., & VALENTIN-OPRAN, A. (2002) · The Journal of Bone and Joint Surgery-American Volume · doi:10.2106/00004623-200212000-00001 · Cited by 1,308
Engineering Substrate Topography at the Micro‐ and Nanoscale to Control Cell Function
Bettinger, C. J., Langer, R., & Borenstein, J. T. (2009) · Angewandte Chemie International Edition · doi:10.1002/anie.200805179 · Cited by 1,258
Friess, W. (1998) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/s0939-6411(98)00017-4 · Cited by 1,130
Repair of bone defects using synthetic mimetics of collagenous extracellular matrices
Lutolf, M. P., Weber, F. E., Schmoekel, H. G., Schense, J. C., Kohler, T., Müller, R., & Hubbell, J. A. (2003) · Nature Biotechnology · doi:10.1038/nbt818 · Cited by 850
Antigenicity and immunogenicity of collagen
Lynn, A. K., Yannas, I. V., & Bonfield, W. (2004) · Journal of Biomedical Materials Research Part B: Applied Biomaterials · doi:10.1002/jbm.b.30096 · Cited by 823
Chevallay, B., & Herbage, D. (2000) · Medical & Biological Engineering & Computing · doi:10.1007/bf02344779 · Cited by 403
Adverse reactions to injectable soft tissue fillers
Requena, L., Requena, C., Christensen, L., Zimmermann, U. S., Kutzner, H., & Cerroni, L. (2011) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2010.02.064 · Cited by 338
Type II Collagen Autoimmunity in Animals and Provocations Leading to Arthritis
Holmdahl, R., Andersson, M., Goldschmidt, T. J., Gustafsson, K. E., Jansson, L., & Mo, J. A. (1990) · Immunological Reviews · doi:10.1111/j.1600-065x.1990.tb00817.x · Cited by 307
Recombinant Human Bone Morphogenetic Protein-2 for Treatment of Open Tibial Fractures
Starr, A. J. (2003) · The Journal of Bone and Joint Surgery-American Volume · doi:10.2106/00004623-200310000-00027 · Cited by 297
Collagen-based devices for soft tissue repair
Pachence, J. M. (1996) · Journal of Biomedical Materials Research · doi:10.1002/(sici)1097-4636(199621)33:1<35::aid-jbm6>3.0.co;2-n · Cited by 288
Functional Biomaterials for Bone Regeneration: A Lesson in Complex Biology
Armiento, A. R., Hatt, L. P., Sanchez Rosenberg, G., Thompson, K., & Stoddart, M. J. (2020) · Advanced Functional Materials · doi:10.1002/adfm.201909874 · Cited by 273
Materials for Peripheral Nerve Regeneration
Ciardelli, G., & Chiono, V. (2006) · Macromolecular Bioscience · doi:10.1002/mabi.200500151 · Cited by 255
Immunogenicity in xenogeneic scaffold generation: Antigen removal vs. decellularization
Wong, M. L., & Griffiths, L. G. (2014) · Acta Biomaterialia · doi:10.1016/j.actbio.2014.01.028 · Cited by 254
Aro, H. T., Govender, S., Patel, A. D., Hernigou, P., Perera de Gregorio, A., Popescu, G. I., Golden, J. D., Christensen, J., & Valentin, A. (2011) · Journal of Bone and Joint Surgery · doi:10.2106/jbjs.i.01763 · Cited by 180
The host response to naturally-derived extracellular matrix biomaterials
Morris, A. H., Stamer, D. K., & Kyriakides, T. R. (2017) · Seminars in Immunology · doi:10.1016/j.smim.2017.01.002 · Cited by 180
Bayrak, A., Tyralla, M., Ladhoff, J., Schleicher, M., Stock, U. A., Volk, H.-D., & Seifert, M. (2010) · Biomaterials · doi:10.1016/j.biomaterials.2010.01.120 · Cited by 96
Metadata
- Authors
- Ellingsworth, L. R., DeLustro, F., Brennan, J. E., Sawamura, S., & McPherson, J.
- Venue
- The Journal of Immunology
- Publisher
- Oxford University Press (OUP)
- Published
- 1986-02-01
- Volume
- 136
- Issue
- 3
- Pages
- 877-882
- ISSN
- 0022-1767 (ISSN-L)
- 1550-6606
- OpenAlex
- W1755214722
- Cited by
- 170
- References
- 0
- FWCI
- 7.20
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.